Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Axogen
AddedFeb 19, 2024
UpdatedJul 4, 2026
Axogen

Axogen

Public

Florida-based Axogen, Inc. manufactures and distributes medical instruments for nerve reconstruction and regeneration.

HQ
Alachua, FL, US
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Founded on January 1, 2002, Axogen, Inc. is a Florida-based company specializing in the development and distribution of medical instruments for peripheral nerve reconstruction and regeneration. The company's core mission is to restore functionality and sensation to patients suffering from nerve damage. Axogen's product portfolio includes human tissue grafts, nerve connectors, and soft tissue membranes, with its flagship technology being AVANCE, a cell graft that mimics human nerves. The company primarily serves medical professionals and patients experiencing chronic pain or loss of function due to nerve damage.

Axogen is publicly traded on Nasdaq under the ticker AXGN and is a component of the Russell 2000 Index. In 2013, the company successfully raised $18 million through its initial public offering (IPO). Notable achievements include the widespread adoption of its nerve repair solutions in the medical community, significantly impacting patient recovery outcomes. Axogen's innovative approach has positioned it as a leader in the nerve repair industry, contributing to advancements in surgical techniques and improving the quality of life for countless patients.

Axogen - Quick Facts

When was Axogen founded?

Axogen was founded in 2002.

Where is Axogen's headquarters located?

Axogen's headquarters is located in Alachua, FL, US.

When was Axogen's last funding round?

Axogen's most recent funding round was for $17.5M (USD) in August 2015.

How much has Axogen raised to-date?

As of Aug 28, 2015, Axogen has raised a total of $90.9M (USD).

How many employees does Axogen have?

Axogen has 396 employees as of Feb 6, 2024.

Axogen - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Instruments
Tags
  • Healthtech
Unique IDs
  • secCik: 0000805928
  • ticker: AXGN
NAICS
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334517Irradiation Apparatus Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3845Electromedical And Electrotherapeutic Apparatus
ISIC
  • 2660Manufacture of irradiation, electromedical and electrotherapeutic equipment
Show 27 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 621000Ambulatory Health Care Services
  • 621300Offices of Other Health Practitioners
  • 621390Offices of All Other Health Practitioners
  • 621399Offices of All Other Miscellaneous Health Practitioners
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 5040Professional And Commercial Equipment And Supplies
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 8690Other human health activities